Ben Sprangers

46PUBLICATIONS
151CO-AUTHORS
Regenerative medicine (incl. stem cells)Cardiology (incl. cardiovascular diseases)Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cross-sectional analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Jun 24, 2026
Executive summary of the European consensus report on the diagnosis and treatment of monoclonal gammopathy of renal significance.

|Apr 08, 2026
Large-scale AI analysis reveals missed opportunities in albuminuria testing and disease-modifying therapy implementation.

Marnicq van Es, Jonas Erzeel, Michiel De Wever

|Feb 27, 2026
Malignancy of Urinary Tract in Kidney Transplant Recipients-A Narrative Review.

Sławomir Jerzy Małyszko, Letycja Rog, Ben Sprangers

|Dec 09, 2025
The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroup.

Amanda DeMauro Renaghan, Marlies Ostermann, Claudio Ronco

|Apr 10, 2025
Primary FSGS is not associated with worse kidney outcome compared with other FSGS subtypes.

Dries Deleersnijder, Evert Cleenders, Maarten Coemans

|Jun 24, 2024
Cancer therapy in patients with reduced kidney function.

Sabine Karam, Mitchell H Rosner, Ben Sprangers

Pageof 8

Frequent Collaborators

10 joint publications

Maarten Naesens

7 joint publications

Aleksandar Senev

7 joint publications

Dirk Kuypers

5 joint publications

Marie-Paule Emonds